Elwell R J, Bailie G R, Manley H J
Albany College of Pharmacy, New York 12208, USA.
Perit Dial Int. 2000 Nov-Dec;20(6):694-8.
To identify correlations between the pharmacokinetic variables that describe drug disposition in peritoneal dialysis (PD) patients and the measures used to assess dialysis adequacy.
This retrospective study re-evaluated data collected during previous pharmacokinetic studies for intraperitoneally administered cefazolin, ceftazidime, and gentamicin in continuous ambulatory peritoneal dialysis (CAPD) patients, and intravenous cefazolin and tobramycin in automated PD patients. Pharmacokinetic variables were compared to creatinine clearance (CCr), Kt/V, and peritoneal equilibration test data using the Pearson product correlation coefficient (r).
Prominent correlations were found between renal CCr and renal Kt/V, with renal clearances of CAPD cefazolin and ceftazidime, and automated PD tobramycin and cefazolin (r values ranged from 0.698 to 0.986; p < 0.05).
These findings support current peritonitis treatment recommendations that patients with residual renal function may require higher doses or more frequent drug administration.
确定描述腹膜透析(PD)患者药物处置的药代动力学变量与用于评估透析充分性的指标之间的相关性。
这项回顾性研究重新评估了先前药代动力学研究中收集的数据,这些研究涉及持续性非卧床腹膜透析(CAPD)患者腹腔内给予头孢唑林、头孢他啶和庆大霉素,以及自动化腹膜透析患者静脉给予头孢唑林和妥布霉素。使用Pearson积差相关系数(r)将药代动力学变量与肌酐清除率(CCr)、Kt/V和腹膜平衡试验数据进行比较。
在肾CCr与肾Kt/V之间发现显著相关性,CAPD患者的头孢唑林和头孢他啶以及自动化腹膜透析患者的妥布霉素和头孢唑林的肾清除率之间也存在显著相关性(r值范围为0.698至0.986;p<0.05)。
这些发现支持当前的腹膜炎治疗建议,即有残余肾功能的患者可能需要更高剂量或更频繁的药物给药。